NCT06518616 Meditation to Reduce Firefighter Distress
| NCT ID | NCT06518616 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | University of Arizona |
| Condition | Psychological Distress |
| Study Type | INTERVENTIONAL |
| Enrollment | 192 participants |
| Start Date | 2024-12-03 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 192 participants in total. It began in 2024-12-03 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The more than one million firefighters in the United States provide critical emergency medical services in communities they serve and are on the front lines of healthcare delivery, including in the post-pandemic world. As a result of exposure to occupational stressors, a high proportion of firefighters experience considerable stress-related burden including psychological distress (i.e., increased features of anxiety and depression). To address this need, this project will test the efficacy of a 10-day meditation intervention (i.e., 10 individual prerecorded audio units delivered by smartphone app) among career firefighters to decrease psychological distress (i.e., anxiety and depression).
Eligibility Criteria
Inclusion criteria: 1) currently employed as a career firefighter, 2) 18 or older, 3) speak and understand English, and 4) own a smartphone (iPhone or Android) able to download and run the intervention apps. Exclusionary factors: 1) diagnosis of an illness requiring use of corticosteroids (e.g., asthma), and 2) have ongoing or past regular meditation experience in the last 4 years (i.e. more than two meditation session \[completed or attempted\] per year either with a group or individually), as determined by the PI.
Contact & Investigator
Thaddeus Pace, PhD
PRINCIPAL INVESTIGATOR
University of Arizona
Frequently Asked Questions
Who can join the NCT06518616 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychological Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06518616 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT06518616 currently recruiting?
Yes, NCT06518616 is actively recruiting participants. Contact the research team at twwpace@arizona.edu for enrollment information.
Where is the NCT06518616 trial being conducted?
This trial is being conducted at Tucson, United States.
Who is sponsoring the NCT06518616 clinical trial?
NCT06518616 is sponsored by University of Arizona. The principal investigator is Thaddeus Pace, PhD at University of Arizona. The trial plans to enroll 192 participants.